The Central Drugs Standard Control Organisation (CDSCO) has issued an important public notice clarifying that cosmetic products cannot be administered through injections. The regulatory authority has warned manufacturers, importers, aesthetic clinics, healthcare professionals, and consumers against the misuse of cosmetic products for injectable treatments.
This clarification aims to protect public health and prevent the growing misuse of cosmetic formulations in aesthetic and beauty procedures.
What Did CDSCO Clarify?
According to the CDSCO notice, products classified as cosmetics under the Drugs and Cosmetics Act, 1940 are legally intended only for external application.
Cosmetics are designed to be:
- Applied on the skin
- Rubbed on the body
- Sprinkled or sprayed externally
- Used for cleansing, beautifying, or altering appearance
However, some cosmetic products are reportedly being promoted or used through injections for aesthetic enhancement, which falls outside the legal definition of cosmetics.
CDSCO has clarified that such practices are not permitted under Indian regulations.
Why Are Injectable Cosmetics a Concern?
Injectable administration involves introducing a substance directly into the body using needles or syringes.
When products intended for external use are injected:
- Safety data may be inadequate
- Risk of infection increases
- Adverse reactions may occur
- Long-term health effects may be unknown
- Product quality and sterility concerns arise
As a result, the use of cosmetic products via injections can pose significant health risks to consumers.
Legal Position Under the Drugs and Cosmetics Act
Under the Drugs and Cosmetics Act, 1940:
Cosmetic Products
Cosmetics are products intended for application on the human body for cleansing, beautifying, promoting attractiveness, or altering appearance.
Injectable Products
Products administered through injections require separate regulatory evaluation regarding:
- Safety
- Efficacy
- Quality
- Sterility
- Clinical use
Any cosmetic product supplied in injectable form does not fall within the legal definition of a cosmetic product.
Therefore, promoting or administering cosmetics through injections may constitute a regulatory violation.
Who Has Been Warned?
The CDSCO advisory specifically targets:
Manufacturers
Manufacturers must ensure that cosmetic products are marketed only for approved uses and routes of administration.
Importers
Imported cosmetic products should comply with Indian regulatory requirements and should not be promoted for injectable use.
Aesthetic Clinics
Beauty and aesthetic centers must avoid administering cosmetic products through injections unless the products are legally approved for such use.
Healthcare Professionals
Practitioners should follow approved indications and routes of administration to ensure patient safety.
Consumers
Consumers are advised to verify the regulatory status of cosmetic procedures before undergoing treatment.
Impact on the Aesthetic Industry
India’s aesthetic and cosmetic treatment sector has witnessed rapid growth in recent years.
Popular procedures include:
- Skin rejuvenation treatments
- Anti-aging therapies
- Cosmetic enhancements
- Beauty injections
The CDSCO clarification is expected to strengthen regulatory oversight and encourage clinics and practitioners to use only legally approved products for injectable procedures.
Importance of Patient Safety
Patient safety remains the primary objective of this regulatory action.
The notice aims to:
- Prevent misuse of cosmetic products
- Reduce adverse events
- Improve treatment safety
- Strengthen consumer awareness
- Ensure compliance with Indian drug and cosmetic regulations
Consumers should always seek treatment from qualified professionals and inquire about the regulatory approval status of any injectable product being used.
What Should Consumers Do?
Before undergoing any cosmetic or aesthetic injection procedure:
✔ Verify the credentials of the clinic and practitioner.
✔ Ask whether the product is approved for injectable use.
✔ Request information regarding safety and possible side effects.
✔ Avoid treatments involving unverified or unapproved products.
✔ Report any adverse reactions to healthcare authorities.
Conclusion
The CDSCO’s latest clarification serves as an important reminder that cosmetic products are intended for external use and cannot be administered through injections unless specifically approved under applicable regulations.
As the cosmetic and aesthetic industry continues to grow, strict compliance with regulatory standards is essential to protect consumer health and maintain public confidence in cosmetic treatments.
The advisory reinforces CDSCO’s commitment to ensuring safety, quality, and responsible use of healthcare and cosmetic products across India.
Recommended Products
